Author name: Open Medscience

Open MedScience is a dedicated platform designed to facilitate discussions on a broad spectrum of medical imaging technologies. Our focus encompasses proton therapy, radiosurgery, nuclear medicine, radiation therapy, radiotheranostics, and radiotherapeutic techniques. This comprehensive approach enables us to support advancements in medical imaging and treatment methodologies.

Hospital budgeting improves efficiency, reduces costs, and enhances patient care quality
Health Matters

Managing Budgets and Equipment: How Hospitals Invest Smarter for Better Care

Hospital budgeting requires strategic planning to allocate resources efficiently, ensuring cost-effective equipment management, staff training, and patient care.

Managing Budgets and Equipment: How Hospitals Invest Smarter for Better Care Read Article »

, , , ,
Auger electrons precisely destroy cancer cells while sparing healthy tissue
Radiotherapeutics

Selected Auger Electron-Emitting Radionuclides for Therapeutic Nuclear Medicine

Auger electron-emitting radionuclides offer innovative therapeutic potential through highly localised DNA damage with minimal collateral effects.

Selected Auger Electron-Emitting Radionuclides for Therapeutic Nuclear Medicine Read Article »

, , , , ,
Alpha particle radionuclides deliver precise, powerful radiation for targeted therapy
Radiotherapeutics

Selected Alpha Particle Emitting Radionuclides for Therapeutic Nuclear Medicine

Alpha particle emitting radionuclides are highly effective in delivering targeted radiation therapy for various cancers.

Selected Alpha Particle Emitting Radionuclides for Therapeutic Nuclear Medicine Read Article »

, , , , ,
PRRT targets tumours, delivering radiation while sparing surrounding healthy tissues
Radiotherapeutics

Peptide Receptor Radionuclide Therapy (PRRT): A Breakthrough in Treating Gastroenteropancreatic Neuroendocrine Tumours

Peptide Receptor Radionuclide Therapy utilises radiopharmaceuticals to target somatostatin receptor-expressing tumours, improving treatment outcomes significantly.

Peptide Receptor Radionuclide Therapy (PRRT): A Breakthrough in Treating Gastroenteropancreatic Neuroendocrine Tumours Read Article »

, ,
Innovative technologies enhance chronic disease management and improve patient outcomes
Medicine

Innovations in Chronic Disease Management: A New Frontier for Diabetes, Cardiovascular Disease, and Hypertension

Chronic disease management focuses on improving patient outcomes through personalised care, preventative measures, and technological advancements.

Innovations in Chronic Disease Management: A New Frontier for Diabetes, Cardiovascular Disease, and Hypertension Read Article »

, ,
ICH Q10 ensures pharmaceutical product quality through effective management
Regulatory Affairs

The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System

ICH Q10 is a global model for managing pharmaceutical quality, ensuring compliance, continuous improvement, and risk manage.

The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System Read Article »

,
brain scan using Pittsburgh Compound-B (PIB) PET imaging, highlighting amyloid plaques as bright spots within the brain
Nuclear Medicine Imaging

The Discovery and Development of Pittsburgh Compound-B (PIB): A Breakthrough in Alzheimer’s Disease Research

Pittsburgh Compound-B allows researchers to visualise amyloid plaques in the brain, aiding in Alzheimer’s disease diagnosis and study.

The Discovery and Development of Pittsburgh Compound-B (PIB): A Breakthrough in Alzheimer’s Disease Research Read Article »

, , ,